Examples of these drugs include insulin analogues for diabetes management (such as insulin lispro and insulin glargine), peptide hormones for growth disorders (such as somatropin), peptide-based medicines for cancer therapy (such as leuprolide and octreotide), and peptide-based biologics for autoimmune diseases (such as adalimumab and ustekinumab) [9]. This evidence concerns the gene INS and diabetes mellitus.